170417 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines Tumor necrosis factor [TNF]
Use of a L. Casei Strain For the Preparation of a Composition for Inhibiting Mast Cell Activation
#302TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING CHOLINERGIC AGONISTS
#303Biomarkers for Atherosclerosis
#304ASSAYS FOR DETERMINING EXPOSURE TO MULTIWALLED CARBON NANOTUBES
#305Use of the Serological Assay of the Cytokine B-Lymphocyte Stimulator (Blys) as a Prognostic and Monitoring Test for Immune-Related Transfusion Reactions
#306Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors
#307Methods for detection of biological substances
#308METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#309Methods of use of the TACI/TACI-L interaction
#310Method for Predicting the Response of a Patient to Treatment with an Anti-TNF Alpha Antibody
#311ANTIBODIES THAT BIND TO OBM
#312SINGLE MOLECULE ASSAYS
#313Development of Diagnostic Markers From the Saliva of Head and Neck Cancer Patients
#3144-1 bb ligand in inflammatory diseases
#315Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
#316THERAPEUTIC COMPOSITION COMPRISING AN INHIBITOR OF AN HSP 90 PROTEIN
#317Dual variable domain immunoglobulins and uses thereof
#318Levels of APRIL in serum and use in diagnostic methods
#319Purified TNFR preparations
#320Modulators of neuronal regeneration
#321Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
#322MESENCHYMAL STEM CELLS EXPRESSING TNF-A RECEPTOR
#323Methods for determining anti-TNF therapeutic response
#324Treatment of inflammation using α7 receptor-binding cholinergic agonists
#325INHIBITION OF TRISTETRAPROLINE FOR PROTECTION OF THE HEART FROM CARDIAC INJURIES
#326Methods of use of the TACI/TACI-L interaction
#327Stationary Phase Antibody Arrays for Trace Protein Analysis
#328Method for determining in vivo biopharmaceutical concentration or bioavailability
#329Treatment of trauma-hemorrhage with short oligopeptides
#330Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
#331Composition and method for modulating an inflammatory response
#332Antibodies to OCIF-binding molecules
#333Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
#334Pharmaceutical compositions for treating arthritis and inflammatory disease
#335EPITOPES FORMED BY NON-COVALENT ASSOCIATION OF CONJUGATES
#336PHARMACEUTICAL COMPOSITIONS FOR TREATING ARTHRITIS AND INFLAMMATORY DISEASE
#337Antibody profiling for determination of patient responsiveness
#338Recombinant polypeptides of the members of the TNF ligand family and use thereof
#339Methods for producing ex vivo models for inflammatory disease and uses thereof
#340Process for the Identification of New Medical Targets
#341COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS AND CONDITIONS
#342Mesenchymal stem cells expressing TNF-alpha receptors
#343Methods and compositions related to B cell assays
#344Domain antibody construct
#345Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
#346Therapeutic composition
#347Nucleic acids encoding human TNF-α convertase
#348Antibodies to OCIF-binding molecules
#349Diagnostic test
#350Nuclear matrix protein fluid assay
#351Gene expression profiling for identification monitoring and treatment of multiple sclerosis
#352Glycoproteins which bind to TNF
#353TNFr/OPG-like molecules and uses thereof
#354Screening method for identifying compounds that selectively induce interferon alpha
#355Novel protein and method for producing the protein
#356Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
#357Treatment of inflammatory disease by cleaving TNF receptors
#358Methods for producing Ex vivo models for inflammatory disease and uses thereof
#359Treating arthritis by cleaving TNF receptors
#360Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
#361Screening for gestational disorders
#362Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
#363Pharmaceutical compositions for treating arthritis and inflammatory disease
#364Inhibition of tristetraproline for protection of the heart from cardiac injuries
#365Novel complementing receptor-ligand pairs and adoptive immunotherapy using the same
#366Nuclear matrix protein fluid assay
#367Compositions and methods for the treatment of depression and other affective disorders
#368Novel molecules of the herpesvirus-entry-mediator-related protein family and uses thereof
#369Antibodies to OCIF-binding molecules